Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul 16;9(7):e0003846.
doi: 10.1371/journal.pntd.0003846. eCollection 2015.

Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks

Affiliations
Review

Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks

Marc Lipsitch et al. PLoS Negl Trop Dis. .

Abstract

Estimating the case-fatality risk (CFR)-the probability that a person dies from an infection given that they are a case-is a high priority in epidemiologic investigation of newly emerging infectious diseases and sometimes in new outbreaks of known infectious diseases. The data available to estimate the overall CFR are often gathered for other purposes (e.g., surveillance) in challenging circumstances. We describe two forms of bias that may affect the estimation of the overall CFR-preferential ascertainment of severe cases and bias from reporting delays-and review solutions that have been proposed and implemented in past epidemics. Also of interest is the estimation of the causal impact of specific interventions (e.g., hospitalization, or hospitalization at a particular hospital) on survival, which can be estimated as a relative CFR for two or more groups. When observational data are used for this purpose, three more sources of bias may arise: confounding, survivorship bias, and selection due to preferential inclusion in surveillance datasets of those who are hospitalized and/or die. We illustrate these biases and caution against causal interpretation of differential CFR among those receiving different interventions in observational datasets. Again, we discuss ways to reduce these biases, particularly by estimating outcomes in smaller but more systematically defined cohorts ascertained before the onset of symptoms, such as those identified by forward contact tracing. Finally, we discuss the circumstances in which these biases may affect non-causal interpretation of risk factors for death among cases.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Illustration of delayed reporting bias in an exponentially growing epidemic.
In an ongoing epidemic, there will typically be a delay between the reporting of a case and the reporting of the death of that case, if the infected person dies. Thus, at any moment, there will be some cases reported who will die of the infection but who have not yet died, or whose deaths have not yet been reported. Simple division of the number of deaths reported by week w (green), by the number of cases reported by week w (blue) will underestimate the CFR because the numerator does not include all those cases in the denominator who will eventually die. With a reporting delay of 3 weeks for deaths compared to cases, the reported deaths curve will be shifted 3 weeks to the right, relative to the curve of the total number of cases reported by week w who will die (red). If the epidemic doubling time is 2 weeks, as shown here, the underestimate of CFR will be by a factor of about 23/2 ≈ 2.8, with the exponent being the number of epidemic doubling times that pass between case reporting and death reporting. In reality, there will be a distribution of reporting delays rather than a fixed delay, making this a heuristic rather than exact approach. The problem is ameliorated in an epidemic that grows more slowly or less than exponentially. For more details, see references in Table 1.

Similar articles

Cited by

References

    1. Van Kerkhove MD, Asikainen T, Becker NG, Bjorge S, Desenclos JC, et al. (2010) Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med 7: e1000275 10.1371/journal.pmed.1000275 - DOI - PMC - PubMed
    1. US Department of Health and Human Services (2007) Interim pre-pandemic planning guidance: Community strategy for pandemic influenza mitigation in the United States—Early targeted layered use of nonpharmaceutical interventions Department of Health and Human Services; Washington, DC.
    1. Adebamowo C, Bah-Sow O, Binka F, Bruzzone R, Caplan A, et al. (2014) Randomised controlled trials for Ebola: practical and ethical issues. Lancet 384: 1423–1424. 10.1016/S0140-6736(14)61734-7 - DOI - PMC - PubMed
    1. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, et al. (2014) Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis 14: 50–56. 10.1016/S1473-3099(13)70304-9 - DOI - PMC - PubMed
    1. Lipsitch M, Finelli L, Heffernan RT, Leung GM, Redd SC (2011) Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1. Biosecur Bioterror 9: 89–115. 10.1089/bsp.2011.0007 - DOI - PMC - PubMed

Publication types